000 | 01967 a2200553 4500 | ||
---|---|---|---|
005 | 20250516163913.0 | ||
264 | 0 | _c20131127 | |
008 | 201311s 0 0 eng d | ||
022 | _a1756-6606 | ||
024 | 7 |
_a10.1186/1756-6606-6-35 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAgeta-Ishihara, Natsumi | |
245 | 0 | 0 |
_aChronic overload of SEPT4, a parkin substrate that aggregates in Parkinson's disease, causes behavioral alterations but not neurodegeneration in mice. _h[electronic resource] |
260 |
_bMolecular brain _cAug 2013 |
||
300 |
_a35 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 |
_aCircadian Rhythm _xdrug effects |
650 | 0 | 4 |
_aDopamine _xmetabolism |
650 | 0 | 4 |
_aDopamine Plasma Membrane Transport Proteins _xmetabolism |
650 | 0 | 4 |
_aExploratory Behavior _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMethamphetamine _xpharmacology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aNeostriatum _xdrug effects |
650 | 0 | 4 |
_aNerve Degeneration _xcomplications |
650 | 0 | 4 |
_aParkinson Disease _xcomplications |
650 | 0 | 4 |
_aPeptides _xmetabolism |
650 | 0 | 4 | _aProtein Structure, Quaternary |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aSeptins _xchemistry |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 |
_aSubstrate Specificity _xdrug effects |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
650 | 0 | 4 |
_aUbiquitin-Protein Ligases _xmetabolism |
650 | 0 | 4 |
_aalpha-Synuclein _xmetabolism |
700 | 1 | _aYamakado, Hodaka | |
700 | 1 | _aMorita, Takao | |
700 | 1 | _aHattori, Satoko | |
700 | 1 | _aTakao, Keizo | |
700 | 1 | _aMiyakawa, Tsuyoshi | |
700 | 1 | _aTakahashi, Ryosuke | |
700 | 1 | _aKinoshita, Makoto | |
773 | 0 |
_tMolecular brain _gvol. 6 _gp. 35 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1756-6606-6-35 _zAvailable from publisher's website |
999 |
_c22997336 _d22997336 |